Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × pertuzumab × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 58 Neoplasms 8 HER2-positive Breast Cancer 8 Neoplasm Metastasis 3 Endometrial Neoplasms 3 Colonic Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Inflammatory Breast Neoplasms 2 Hematologic Neoplasms 2 HER2-positive Early Breast Cancer 2 Brain Neoplasms 2 Biliary Tract Neoplasms 2 Anatomic Stage II Breast Cancer AJCC v8 2 Urinary Bladder Neoplasms 1 Solid Tumors 1 Solid Cancer 1 Skin Neoplasms 1 Resectable HER2-positive Breast Cancer 1 Recurrence 1 Rectal Neoplasms 1 Patient Preference 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1

Interventions

Azacitidine 29 venetoclax 21 Cyclophosphamide 17 Whole-Body Irradiation 14 fludarabine phosphate 13 Biopsy 13 fludarabine 12 Tacrolimus 12 Specimen Handling 12 Mycophenolic Acid 11 Decitabine 11 Cytarabine 10 Stem Cell Transplantation 9 Peripheral Blood Stem Cell Transplantation 9 Injections 8 decitabine and cedazuridine drug combination 7 Melphalan 7 Busulfan 6 X-Rays 5 Hematopoietic Stem Cell Transplantation 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Cyclosporine 4 sabatolimab 3 olutasidenib 3 enasidenib 3 cedazuridine 3 Sirolimus 3 Rituximab 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡